Search

Your search keyword '"Cornelissen, Jan"' showing total 14 results
Start Over Author "Cornelissen, Jan" Journal american journal of hematology
14 results on '"Cornelissen, Jan"'

1. BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis

Author

Kockerols, Camille, primary, Valk, Peter J. M., additional, Dulucq, Stéphanie, additional, Nicolini, Franck‐Emmanuel, additional, Mahon, François‐Xavier, additional, Atallah, Ehab, additional, Mauro, Michael J., additional, Radich, Jerald P., additional, Bernardi, Simona, additional, Russo, Domenico, additional, Farina, Mirko, additional, Mori, Silvia, additional, Gambacorti‐Passerini, Carlo, additional, Civettini, Ivan, additional, Lu, Liu, additional, Yeung, David, additional, Branford, Susan, additional, Colafigli, Gioia, additional, Breccia, Massimo, additional, Hogenbirk, Pauline, additional, van Rosmalen, Joost, additional, Cornelissen, Jan J., additional, and Westerweel, Peter E., additional

Published
2024
Full Text
View/download PDF

2. Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Giebel, Sebastian, primary, Labopin, Myriam, additional, Schroeder, Thomas, additional, Swoboda, Ryszard, additional, Maertens, Johan, additional, Bourhis, Jean Henri, additional, Grillo, Giovanni, additional, Salmenniemi, Urpu, additional, Hilgendorf, Inken, additional, Kröger, Nicolaus, additional, Poiré, Xavier, additional, Cornelissen, Jan J., additional, Arat, Mutlu, additional, Savani, Bipin, additional, Spyridonidis, Alexandros, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2023
Full Text
View/download PDF

3. Relatively favorable outcome after allogeneic stem cell transplantation for BCR‐ABL1‐positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

Author

Lazarevic, Vladimir Lj, Labopin, Myriam, Depei, Wu, Yakoub‐Agha, Ibrahim, Huynh, Anne, Ljungman, Per, Schaap, Nicolaas, Cornelissen, Jan J., Maillard, Natacha, Pioltelli, Pietro, Gedde‐Dahl, Tobias, Lenhoff, Stig, Houhou, Mohamed, Esteve, Jordi, Mohty, Mohamad, and Nagler, Arnon

Published
2018
Full Text
View/download PDF

4. Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party / European society of blood and marrow transplantation

Author

Nagler, Arnon, primary, Labopin, Myriam, additional, Craddock, Charles, additional, Socié, Gerard, additional, Yakoub‐Agha, Ibrahim, additional, Gedde‐Dahl, Tobias, additional, Niittyvuopio, Riitta, additional, Byrne, Jennifer Louise, additional, Cornelissen, Jan J., additional, Labussière‐Wallet, Hélène, additional, Arcese, William, additional, Milpied, Noel, additional, Esteve, Jordi, additional, Canaani, Jonathan, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

5. Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry

Author

Hernández‐Boluda, Juan‐Carlos, primary, Pereira, Arturo, additional, Kröger, Nicolaus, additional, Cornelissen, Jan J., additional, Finke, Jürgen, additional, Beelen, Dietrich, additional, de Witte, Moniek, additional, Wilson, Keith, additional, Platzbecker, Uwe, additional, Sengeloev, Henrik, additional, Blaise, Didier, additional, Einsele, Hermann, additional, Sockel, Katja, additional, Krüger, William, additional, Lenhoff, Stig, additional, Salaroli, Adriano, additional, Martin, Hans, additional, García‐Gutiérrez, Valentín, additional, Pavone, Vicenzo, additional, Alvarez‐Larrán, Alberto, additional, Raya, José‐María, additional, Zinger, Nienke, additional, Gras, Luuk, additional, Hayden, Patrick, additional, Czerw, Tomasz, additional, P. McLornan, Donal, additional, and Yakoub‐Agha, Ibrahim, additional

Published
2021
Full Text
View/download PDF

6. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT)

Author

Poiré, Xavier, Labopin, Myriam, Cornelissen, Jan J., Volin, Liisa, Richard Espiga, Carlos, Veelken, Hendrik J., Milpied, Noël, Cahn, Jean-Yves, Yacoub-Agha, Ibrahim, van Imhoff, Gustaaf W., Michallet, Mauricette, Michaux, Lucienne, Nagler, Arnon, and Mohty, Mohamad

Published
2015
Full Text
View/download PDF

7. Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.

Author

Nagler, Arnon, Labopin, Myriam, Craddock, Charles, Socié, Gerard, Yakoub‐Agha, Ibrahim, Gedde‐Dahl, Tobias, Niittyvuopio, Riitta, Byrne, Jennifer Louise, Cornelissen, Jan J., Labussière‐Wallet, Hélène, Arcese, William, Milpied, Noel, Esteve, Jordi, Canaani, Jonathan, and Mohty, Mohamad

Published
2022
Full Text
View/download PDF

8. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation

Author

Poiré, Xavier, primary, Labopin, Myriam, additional, Polge, Emmanuelle, additional, Volin, Liisa, additional, Finke, Jürgen, additional, Ganser, Arnold, additional, Blaise, Didier, additional, Yakoub‐Agha, Ibrahim, additional, Beelen, Dietrich, additional, Forcade, Edouard, additional, Lioure, Bruno, additional, Socié, Gérard, additional, Niederwieser, Dietger, additional, Labussière‐Wallet, Hélène, additional, Maertens, Johan, additional, Cornelissen, Jan, additional, Craddock, Charles, additional, Mohty, Mohamad, additional, Esteve, Jordi, additional, and Nagler, Arnon, additional

Published
2020
Full Text
View/download PDF

9. Relatively favorable outcome after allogeneic stem cell transplantation forBCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

Author

Lazarevic, Vladimir Lj, primary, Labopin, Myriam, additional, Depei, Wu, additional, Yakoub-Agha, Ibrahim, additional, Huynh, Anne, additional, Ljungman, Per, additional, Schaap, Nicolaas, additional, Cornelissen, Jan J., additional, Maillard, Natacha, additional, Pioltelli, Pietro, additional, Gedde-Dahl, Tobias, additional, Lenhoff, Stig, additional, Houhou, Mohamed, additional, Esteve, Jordi, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2017
Full Text
View/download PDF

10. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

Author

Canaani, Jonathan, primary, Savani, Bipin N., additional, Labopin, Myriam, additional, Michallet, Mauricette, additional, Craddock, Charles, additional, Socié, Gerard, additional, Volin, Lisa, additional, Maertens, Johan A., additional, Crawley, Charles, additional, Blaise, Didier, additional, Ljungman, Per T., additional, Cornelissen, Jan, additional, Russell, Nigel, additional, Baron, Frédéric, additional, Gorin, Norbert, additional, Esteve, Jordi, additional, Ciceri, Fabio, additional, Schmid, Christoph, additional, Giebel, Sebastian, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2017
Full Text
View/download PDF

11. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT

Author

Canaani, Jonathan, primary, Labopin, Myriam, additional, Socié, Gerard, additional, Nihtinen, Anne, additional, Huynh, Anne, additional, Cornelissen, Jan, additional, Deconinck, Eric, additional, Gedde-Dahl, Tobias, additional, Forcade, Edouard, additional, Chevallier, Patrice, additional, Bourhis, Jean H., additional, Blaise, Didier, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2017
Full Text
View/download PDF

12. Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT

Author

Canaani, Jonathan, primary, Beohou, Eric, additional, Labopin, Myriam, additional, Socié, Gerard, additional, Huynh, Anne, additional, Volin, Liisa, additional, Cornelissen, Jan, additional, Milpied, Noel, additional, Gedde-Dahl, Tobias, additional, Deconinck, Eric, additional, Fegueux, Nathalie, additional, Blaise, Didier, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2017
Full Text
View/download PDF

13. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.

Author

Lorentino, Francesca, Labopin, Myriam, Bernardi, Massimo, Ciceri, Fabio, Socié, Gerard, Cornelissen, Jan J., Esteve, Jordi, Ruggeri, Annalisa, Volin, Liisa, Yacoub‐Agha, Ibrahim, Craddock, Charles, Passweg, Jacob, Blaise, Didier, Gedde‐Dahl, Tobias, Poiani, Monica, Fegueux, Nathalie, Mohty, Mohamad, and Nagler, Arnon

Published
2018
Full Text
View/download PDF

14. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

Author

Fabio Ciceri, Nigel H. Russell, Mauricette Michallet, Sebastian Giebel, Liisa Volin, Myriam Labopin, Per Ljungman, Christoph Schmid, Johan Maertens, Jordi Esteve, Jonathan Canaani, Charles Craddock, Norbert Claude Gorin, Bipin N. Savani, Arnon Nagler, Mohamad Mohty, Charles Crawley, Gérard Socié, Jan J. Cornelissen, Didier Blaise, Frédéric Baron, Hematology, Canaani, Jonathan, Savani, Bipin N., Labopin, Myriam, Michallet, Mauricette, Craddock, Charle, Sociã©, Gerard, Volin, Lisa, Maertens, Johan A., Crawley, Charle, Blaise, Didier, Ljungman, Per T., Cornelissen, Jan, Russell, Nigel, Baron, Frã©dã©ric, Gorin, Norbert, Esteve, Jordi, Ciceri, Fabio, Schmid, Christoph, Giebel, Sebastian, Mohty, Mohamad, Nagler, Arnon, Clinicum, Hematologian yksikkö, Department of Oncology, and HUS Comprehensive Cancer Center

Subjects
Male, Transplantation Conditioning, IMPACT, Graft vs Host Disease, Gastroenterology, HEMATOLOGIC MALIGNANCIES, 0302 clinical medicine, Retrospective Studie, HLA Antigens, hemic and lymphatic diseases, VERSUS-HOST-DISEASE, HLA Antigen, Transplantation, Homologou, OUTCOMES, Acute leukemia, Incidence (epidemiology), Hazard ratio, Graft Survival, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Hematology, Middle Aged, 3. Good health, Leukemia, Myeloid, Acute, Treatment Outcome, 030220 oncology & carcinogenesis, Blood Group Incompatibility, Female, Survival Analysi, Unrelated Donors, Human, Adult, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, Adolescent, 3122 Cancers, 03 medical and health sciences, Young Adult, ABO blood group system, Internal medicine, parasitic diseases, medicine, Humans, Transplantation, Homologous, Aged, Retrospective Studies, Unrelated Donor, business.industry, MORTALITY, CORD BLOOD TRANSPLANTATION, medicine.disease, BONE-MARROW-TRANSPLANTATION, COMPATIBILITY, Survival Analysis, biological factors, Confidence interval, Transplantation, RECIPIENTS, Graft-versus-host disease, 3121 General medicine, internal medicine and other clinical medicine, Immunology, RISK-FACTORS, business, 030215 immunology
Abstract

ABO incompatibility is commonly observed in stem cell transplantation and its impact in this setting has been extensively investigated. HLA-mismatched unrelated donors (MMURD) are often used as an alternative stem cell source but are associated with increased transplant related complications. Whether ABO incompatibility affects outcome in MMURD transplantation for acute myeloid leukemia (AML) patients is unknown. We evaluated 1,013 AML patients who underwent MMURD transplantation between 2005 and 2014. Engraftment rates were comparable between ABO matched and mismatched patients, as were relapse incidence [34%; 95% confidence interval (CI), 28-39; for ABO matched vs. 36%; 95% CI, 32-40; for ABO mismatched; P = .32], and nonrelapse mortality (28%; 95% CI, 23-33; for ABO matched vs. 25%; 95% CI, 21-29; for ABO mismatched; P = .2). Three year survival was 40% for ABO matched and 43% for ABO mismatched patients (P = .35), Leukemia free survival rates were also comparable between groups (37%; 95% CI, 32-43; for ABO matched vs. 38%; 95% CI, 33-42; for ABO mismatched; P = .87). Incidence of grade II-IV acute graft versus host disease was marginally lower in patients with major ABO mismatching (Hazard ratio of 0.7, 95% CI, 0.5-1; P = .049]. ABO incompatibility probably has no significant clinical implications in MMURD transplantation. ispartof: American Journal of Hematology vol:92 issue:8 pages:789-796 ispartof: location:United States status: published

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results